P4 Medicine Update header 

    July 28, 2011

In This Issue

Benign or Cancerous? Gene Test Predicts Cancer Potential in Pancreatic Cysts  

 

NCHPEG to Hold 14th Annual Meeting  

 

Researchers Identify New Genetic Risk Factor for Sudden Cardiac Death

 

The Ghost of Personalized Medicine

 

Screening New Colon Cancer Patients for Lynch Syndrome Would Be Cost-Effective, Study Shows

 

P4 Medicine Update 7/11/11

 

Ohio State News and Events

  

$3.2 Million Awards Further Study of Air Pollution and Disease

 

Indirubin: Component  of Chinese Herbal Remedy Might Block Brain Tumor's Spread 

 

Omega-3 Reduces Anxiety and Inflammation in Healthy Students  

 

Ohio State Receives $1.4 Million for Burn Wound Care Research 

  

Ohio State Hosts Fourth Annual Personalized Health Care National Conference

 

 Stay connected. Follow us on Facebook Find us on Facebook 

 

 

Join the conversation today!.  

Visit our blog

 

RECENT BLOG POSTS

  

Video: Ohio State Experts Discuss Investing in Health and Wellness

 

Read about Exclusive Personalized Medicine Program at Ohio State

 

 

Visit Ohio State's Center for Personalized Health Care site to learn more about P4 Medicine.

 


COLLABORATORS

 

ISB logo 160 pixels wide

 

Coriell logo 160 pixels wide    

PMC logo 160 pixels wide 

 

  

 

         

Predict JPEG

Gene Test Predicts Cancer Potential in Pancreatic Cysts

Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts.  The test may eventually help some patients avoid needless surgery to remove the harmless variety. Read more...

 

National Coalition for Health Professional Education in Genetics to Hold 14th Annual Meeting, Sept. 26-27

With the theme "Strategies for Evidence-Based Education in Genetics" this year's meeting provides an opportunity for health professionals, educators, patient advocates and researchers to come together to learn about advances in genomics and the challenges and opportunities in the development, dissemination and evaluation of genomics education for diverse audiences. Please visit www.nchpeg.org for more information.

 

prevent icon wide

Researchers Identify New Genetic Risk Factor for Sudden Cardiac Death

Researchers have discovered a variation in the genome's DNA sequence that is linked to a significant increase in a person's risk of SCD. Understanding how genetic variation plays a role in the risk of SCD could eventually help those at risk take steps to prevent it, the researchers say, although they emphasize that a great deal of follow-up work is required. Read more...

                   Personalize JPEG

The Ghost of Personalized Medicine 

The US Food and Drug Administration recommends that doctors genotype patients before prescribing more than 70 commonly-used medications for specific genetic biomarkers. These tests, the agency suggests, can help physicians identify those in which the drug is less efficacious, poorly metabolized, or dangerous. But medicine is still far from a day when drugs and treatment regimes are fitted precisely to a patient's genomic profile. Read more... 

 

participate icon wideScreening New Colon Cancer Patients for Lynch Syndrome Would Be Cost-Effective, Study Shows

Screening every new colon cancer patient for a particular familial disorder extends lives at a reasonable cost, say Stanford University School of Medicine researchers. Lynch syndrome patients can take defensive steps (such as yearly colonoscopies) that can either prevent cancer or alert them to get cancer treatment early, when it has the best chance of working. Read more...  

 

  

 

REGISTER TODAY! 

 

Ohio State's Fourth Annual Personalized Health Care National Conference titled The Ralph and Johanna DeStefano Personalized Health Care Conference "The Future of P4 Medicine and Its Impact on Clinical Care" will be held October 6-7 at the Blackwell Inn, located on the campus of The Ohio State University.

 

  

    

A service brought to you by The Ohio State University Medical Center, "P4 Medicine Update" is a compilation of industry news and research developments relevant to the advancement of predictive, preventive, personalized and participatory medicine. 
 

The The Ohio State University Center for Personalized Health Care 
 
193 McCampbell Hall 1581 Dodd Dr. 

Columbus, OH 43210
614.366.3410

  

To subscribe/unsubscribe, contact Sherri L. Kirk.

  

  

P4 Medicine Institute logo

Ohio State is a founding member of the P4 Medicine Institute (P4MI). P4MI is the world's only organization dedicated to accelerating the emergence and adoption of health care that is predictive, preventive, personalized and participatory.